APO RESEARCH · REPORT
fNIRS Brain Imaging System
Functional Near-infrared Spectroscopy (fNIRS) is a device designed to detect changes in the concentration of oxygenated (oxyHb) and deoxygenated (deoxyHb) haemoglobin molecules in the blood, a method commonly used to assess cerebral activity. fNIRS is a type of functional neuroimaging technology that offers a relatively non-invasive, safe, portable, and low-cost method of indirect and direct monitoring of brain activity.
Product & engineering
Understand the product.
Functional Near-infrared Spectroscopy (fNIRS) is a device designed to detect changes in the concentration of oxygenated (oxyHb) and deoxygenated (deoxyHb) haemoglobin molecules in the blood, a method commonly used to assess cerebral activity. fNIRS is a type of functional neuroimaging technology that offers a relatively non-invasive, safe, portable, and low-cost method of indirect and direct monitoring of brain activity.
Selected research
Market Outlook & Growth Opportunities
Global fNIRS Brain Imaging System Market Outlook and Growth Opportunities 2026
Market perspective
Functional Near-infrared Spectroscopy (fNIRS) is a device designed to detect changes in the concentration of oxygenated (oxyHb) and deoxygenated (deoxyHb) haemoglobin molecules in the blood, a method commonly used to assess cerebral activity. fNIRS is a type of functional neuroimaging technology that offers a relatively non-invasive, safe, portable, and low-cost method of indirect and direct monitoring of brain activity.
Global fNIRS brain imaging system companies include Hitachi, Shimadzu Corporation, Artinis, NIRx and OBELAB, etc. Global top 2 companies hold a share over 63%. Asia-Pacific is the largest market, with a share about 55%, followed by North America and Europe.In terms of product, desk type is the largest segment, with a share over 65%. And in terms of application, the largest application is university, followed by hospital.
This report provides an overview of the global fNIRS Brain Imaging System market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of fNIRS Brain Imaging System and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents fNIRS Brain Imaging System sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the fNIRS Brain Imaging System market size, projected growth trends, production technologies, key applications, and end-use industries.
fNIRS Brain Imaging System Segment by Company
Hitachi
Shimadzu Corporation
Artinis
NIRx
OBELAB
Biopac
Huichuang Medical
Gowerlabs
Spectratech
fNIRS Brain Imaging System Segment by Type
Desk Type
Portable Type
fNIRS Brain Imaging System Segment by Application
University
Hospital
Research Institution
Others
fNIRS Brain Imaging System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global fNIRS Brain Imaging System status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions fNIRS Brain Imaging System market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify fNIRS Brain Imaging System significant trends, drivers, influence factors in global and regions.
6. To analyze fNIRS Brain Imaging System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global fNIRS Brain Imaging System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of fNIRS Brain Imaging System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of fNIRS Brain Imaging System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the fNIRS Brain Imaging System market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global fNIRS Brain Imaging System industry.
Chapter 3: Detailed analysis of fNIRS Brain Imaging System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of fNIRS Brain Imaging System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of fNIRS Brain Imaging System in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Desk Type
- Portable Type
Applications
- University
- Hospital
- Research Institution
- Others
Companies covered
- Hitachi
- Shimadzu Corporation
- Artinis
- NIRx
- OBELAB
- Biopac
- Huichuang Medical
- Gowerlabs
- Spectratech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global fNIRS Brain Imaging System Sales Value (2021-2032)
- 1.2.2 Global fNIRS Brain Imaging System Sales Volume (2021-2032)
- 1.2.3 Global fNIRS Brain Imaging System Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 fNIRS Brain Imaging System Market Dynamics
- 2.1 fNIRS Brain Imaging System Industry Trends
- 2.2 fNIRS Brain Imaging System Industry Drivers
- 2.3 fNIRS Brain Imaging System Industry Opportunities and Challenges
- 2.4 fNIRS Brain Imaging System Industry Restraints
3 fNIRS Brain Imaging System Market by Company
- 3.1 Global fNIRS Brain Imaging System Company Revenue Ranking in 2025
- 3.2 Global fNIRS Brain Imaging System Revenue by Company (2021-2026)
- 3.3 Global fNIRS Brain Imaging System Sales Volume by Company (2021-2026)
- 3.4 Global fNIRS Brain Imaging System Average Price by Company (2021-2026)
- 3.5 Global fNIRS Brain Imaging System Company Ranking (2024-2026)
- 3.6 Global fNIRS Brain Imaging System Company Manufacturing Base and Headquarters
- 3.7 Global fNIRS Brain Imaging System Company Product Type and Application
- 3.8 Global fNIRS Brain Imaging System Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global fNIRS Brain Imaging System Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 fNIRS Brain Imaging System Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 fNIRS Brain Imaging System Market by Type
- 4.1 fNIRS Brain Imaging System Type Introduction
- 4.1.1 Desk Type
- 4.1.2 Portable Type
- 4.2 Global fNIRS Brain Imaging System Sales Volume by Type
- 4.2.1 Global fNIRS Brain Imaging System Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global fNIRS Brain Imaging System Sales Volume by Type (2021-2032)
- 4.2.3 Global fNIRS Brain Imaging System Sales Volume Share by Type (2021-2032)
- 4.3 Global fNIRS Brain Imaging System Sales Value by Type
- 4.3.1 Global fNIRS Brain Imaging System Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global fNIRS Brain Imaging System Sales Value by Type (2021-2032)
- 4.3.3 Global fNIRS Brain Imaging System Sales Value Share by Type (2021-2032)
5 fNIRS Brain Imaging System Market by Application
- 5.1 fNIRS Brain Imaging System Application Introduction
- 5.1.1 University
- 5.1.2 Hospital
- 5.1.3 Research Institution
- 5.1.4 Others
- 5.2 Global fNIRS Brain Imaging System Sales Volume by Application
- 5.2.1 Global fNIRS Brain Imaging System Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global fNIRS Brain Imaging System Sales Volume by Application (2021-2032)
- 5.2.3 Global fNIRS Brain Imaging System Sales Volume Share by Application (2021-2032)
- 5.3 Global fNIRS Brain Imaging System Sales Value by Application
- 5.3.1 Global fNIRS Brain Imaging System Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global fNIRS Brain Imaging System Sales Value by Application (2021-2032)
- 5.3.3 Global fNIRS Brain Imaging System Sales Value Share by Application (2021-2032)
6 fNIRS Brain Imaging System Regional Sales and Value Analysis
- 6.1 Global fNIRS Brain Imaging System Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global fNIRS Brain Imaging System Sales by Region (2021-2032)
- 6.2.1 Global fNIRS Brain Imaging System Sales by Region: 2021-2026
- 6.2.2 Global fNIRS Brain Imaging System Sales by Region (2027-2032)
- 6.3 Global fNIRS Brain Imaging System Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global fNIRS Brain Imaging System Sales Value by Region (2021-2032)
- 6.4.1 Global fNIRS Brain Imaging System Sales Value by Region: 2021-2026
- 6.4.2 Global fNIRS Brain Imaging System Sales Value by Region (2027-2032)
- 6.5 Global fNIRS Brain Imaging System Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America fNIRS Brain Imaging System Sales Value (2021-2032)
- 6.6.2 North America fNIRS Brain Imaging System Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe fNIRS Brain Imaging System Sales Value (2021-2032)
- 6.7.2 Europe fNIRS Brain Imaging System Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific fNIRS Brain Imaging System Sales Value (2021-2032)
- 6.8.2 Asia-Pacific fNIRS Brain Imaging System Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America fNIRS Brain Imaging System Sales Value (2021-2032)
- 6.9.2 South America fNIRS Brain Imaging System Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa fNIRS Brain Imaging System Sales Value (2021-2032)
- 6.10.2 Middle East & Africa fNIRS Brain Imaging System Sales Value Share by Country, 2025 VS 2032
7 fNIRS Brain Imaging System Country-level Sales and Value Analysis
- 7.1 Global fNIRS Brain Imaging System Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global fNIRS Brain Imaging System Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global fNIRS Brain Imaging System Sales by Country (2021-2032)
- 7.3.1 Global fNIRS Brain Imaging System Sales by Country (2021-2026)
- 7.3.2 Global fNIRS Brain Imaging System Sales by Country (2027-2032)
- 7.4 Global fNIRS Brain Imaging System Sales Value by Country (2021-2032)
- 7.4.1 Global fNIRS Brain Imaging System Sales Value by Country (2021-2026)
- 7.4.2 Global fNIRS Brain Imaging System Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.5.2 USA fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.9.2 France fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.16.2 China fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.19.2 India fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt fNIRS Brain Imaging System Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt fNIRS Brain Imaging System Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt fNIRS Brain Imaging System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Hitachi
- 8.1.1 Hitachi Company Information
- 8.1.2 Hitachi Business Overview
- 8.1.3 Hitachi fNIRS Brain Imaging System Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Hitachi fNIRS Brain Imaging System Product Portfolio
- 8.1.5 Hitachi Recent Developments
- 8.2 Shimadzu Corporation
- 8.2.1 Shimadzu Corporation Company Information
- 8.2.2 Shimadzu Corporation Business Overview
- 8.2.3 Shimadzu Corporation fNIRS Brain Imaging System Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Shimadzu Corporation fNIRS Brain Imaging System Product Portfolio
- 8.2.5 Shimadzu Corporation Recent Developments
- 8.3 Artinis
- 8.3.1 Artinis Company Information
- 8.3.2 Artinis Business Overview
- 8.3.3 Artinis fNIRS Brain Imaging System Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Artinis fNIRS Brain Imaging System Product Portfolio
- 8.3.5 Artinis Recent Developments
- 8.4 NIRx
- 8.4.1 NIRx Company Information
- 8.4.2 NIRx Business Overview
- 8.4.3 NIRx fNIRS Brain Imaging System Sales, Value and Gross Margin (2021-2026)
- 8.4.4 NIRx fNIRS Brain Imaging System Product Portfolio
- 8.4.5 NIRx Recent Developments
- 8.5 OBELAB
- 8.5.1 OBELAB Company Information
- 8.5.2 OBELAB Business Overview
- 8.5.3 OBELAB fNIRS Brain Imaging System Sales, Value and Gross Margin (2021-2026)
- 8.5.4 OBELAB fNIRS Brain Imaging System Product Portfolio
- 8.5.5 OBELAB Recent Developments
- 8.6 Biopac
- 8.6.1 Biopac Company Information
- 8.6.2 Biopac Business Overview
- 8.6.3 Biopac fNIRS Brain Imaging System Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Biopac fNIRS Brain Imaging System Product Portfolio
- 8.6.5 Biopac Recent Developments
- 8.7 Huichuang Medical
- 8.7.1 Huichuang Medical Company Information
- 8.7.2 Huichuang Medical Business Overview
- 8.7.3 Huichuang Medical fNIRS Brain Imaging System Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Huichuang Medical fNIRS Brain Imaging System Product Portfolio
- 8.7.5 Huichuang Medical Recent Developments
- 8.8 Gowerlabs
- 8.8.1 Gowerlabs Company Information
- 8.8.2 Gowerlabs Business Overview
- 8.8.3 Gowerlabs fNIRS Brain Imaging System Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Gowerlabs fNIRS Brain Imaging System Product Portfolio
- 8.8.5 Gowerlabs Recent Developments
- 8.9 Spectratech
- 8.9.1 Spectratech Company Information
- 8.9.2 Spectratech Business Overview
- 8.9.3 Spectratech fNIRS Brain Imaging System Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Spectratech fNIRS Brain Imaging System Product Portfolio
- 8.9.5 Spectratech Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 fNIRS Brain Imaging System Value Chain Analysis
- 9.1.1 fNIRS Brain Imaging System Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 fNIRS Brain Imaging System Sales Mode & Process
- 9.2 fNIRS Brain Imaging System Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 fNIRS Brain Imaging System Distributors
- 9.2.3 fNIRS Brain Imaging System Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst